NK cells in autoimmune disease

Current Topics in Microbiology and Immunology

Volumn 298, Issue , 2005, Pages 259-277

  Johansson, S ^a   Hall, H ^a   Berg, L ^a   Hoglund P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CELL FUNCTION; CYTOLOGY; DNA POLYMORPHISM; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; SCLERODERMA; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MODELS, IMMUNOLOGICAL; POLYMORPHISM, GENETIC; RATS; RECEPTORS, IMMUNOLOGIC;

EID: 27144520248     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (92)

1. Albertsson PA, Basse PH, Hokland M, Goldfarb RH, Nagelkerke JF, Nannmark U, Kuppen PJ. (2003) NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. Trends Immunol 24:603-609
2. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395-1401
3. Basse PH, Hokland P, Gundersen HJ, Hokland M. (1992) Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. Apmis 100:202-208
4. Baxter AG, Smyth MJ. (2002) The role of NK cells in autoimmune disease. Autoimmunity 35:1-14
5. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ. (1997) A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644
6. Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L. (2002) HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 60:71-76
7. Bix M, Liao NS, Zijlstra M, Loring J, Jaenisch R, Raulet D. (1991) Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349:329-331
8. Cameron AL, Kirby B, Fei W, Griffiths CE. (2002) Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 294:363-369
9. Cameron AL, Kirby B, Griffiths CE. (2003) Circulating natural killer cells in psoriasis. Br J Dermatol 149:160-164
10. Campbell JJ, Qin S, Unutmaz D, Soler D, Murphy KE, Hodge MR, Wu L, Butcher EC. (2001) Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166:6477-6482
11. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. (2003) IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46:255-266
12. Colonna M. (2003) TREMs in the immune system and beyond. Nat Rev Immunol 3:445-453
13. Dalbeth N, Callan MF. (2002) A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheum 46:1763-1772
14. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797-801
15. Djeu JY, Jiang K, Wei S. (2002) A view to a kill: signals triggering cytotoxicity. Clin Cancer Res 8:636-640
16. Dong C, Flavell RA. (2001) Th1 and Th2 cells. Curr Opin Hematol 8:47-51
17. Erkeller-Yusel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. (1993) Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2:227-231
18. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, Caligiuri MA. (2003) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-3057
19. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C. (2004a) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101:16606-16611
20. Ferlazzo G, Thomas D, Lin SL, Goodman K, Morandi B, Muller WA, Moretta A, Munz C. (2004b) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172:1455-1462
21. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343-351
22. Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. (2002a) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373-382
23. Flodström M, Shi FD, Sarvetnick N, Ljunggren HG. (2002b) The natural killer cell-friend or foe in autoimmune disease? Scand J Immunol 55:432-441
24. Fogler WE, Volker K, McCormick KL, Watanabe M, Ortaldo JR, Wiltrout RH. (1996) NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 156:4707-4714
25. Gambelunghe G, Falorni A, Ghaderi M, Laureti S, Tortoioli C, Santeusanio F, Brunetti P, Sanjeevi CB. (1999) Microsatellite polymorphism of the MHC class I chain-related (MIC-A and MIC-B) genes marks the risk for autoimmune Addison's disease. J Clin Endocrinol Metab 84:3701-3707
26. Gambelunghe G, Gerli R, Bocci EB, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A. (2005) Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus. Rheumatology (Oxford) 44:287-292
27. Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Sanjeevi CB. (2000) Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia 43:507-514
28. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327-333
29. Gonzalez A, Katz JD, Mattei MG, Kikutani H, Benoist C, Mathis D. (1997) Genetic control of diabetes progression. Immunity 7:873-883
30. Gray JD, Hirokawa M, Horwitz DA. (1994) The role of transforming growth factor β in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med 180:1937-1942
31. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. (2003) Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci USA 100:9452-9457
32. Grunebaum E, Malatzky-Goshen E, Shoenfeld Y. (1989) Natural killer cells and autoimmunity. Immunol Res 8:292-304
33. Hayakawa Y, Screpanti V, Yagita H, Grandien A, Ljunggren HG, Smyth MJ, Chambers BJ. (2004) NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172:123-129
34. Hoglund P, Ljunggren HG, Ohlen C, Ahrlund-Richter L, Scangos G, Bieberich C, Jay G, Klein G, Karre K. (1988) Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J Exp Med 168:1469-1474
35. Hori S, Takahashi T, Sakaguchi S. (2003) Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 81:331-371
36. Horwitz DA, Gray JD, Ohtsuka K. (1999) Role of NK cells and TGF-β in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect 1:1305-1311
37. Hue S, Mention JJ, Monteiro RC, Zhang S, Cellier C, Schmitz J, Verkarre V, Fodil N, Bahram S, Cerf-Bensussan N, Caillat-Zucman S. (2004) A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21:367-377
38. Johansson SE, Hall H, Bjorklund J, Hoglund P. (2004) Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int Immunol 16:1-11
39. Karre K, Ljunggren HG, Piontek G, Kiessling R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675-678
40. Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. (2002) A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 168:4472-4479
41. Lee IF, Qin H, Trudeau J, Dutz J, Tan R. (2004) Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J Immunol 172:937-942
42. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. (2002) Expression of type 1 (interferon γ) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 99:1273-1281
43. Luszczek W, Manczak M, Cislo M, Nockowski P, Wisniewski A, Jasek M, Kusnierczyk P. (2004) Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65:758-766
44. Mars LT, Novak J, Liblau RS, Lehuen A. (2004) Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks. Trends Immunol 25:471-476
45. Martin MP, Nelson G, Lee JH, Pellett F, Gao X, Wade J, Wilson MJ, Trowsdale J, Gladman D, Carrington M. (2002) Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169:2818-2822
46. H1 priming. Nat Immunol 5:1260-1265
47. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, Tanuma N. (1998) Role of natural killer cells and TCR γδ T cells in acute autoimmune encephalomyelitis. Eur J Immunol 28:1681-1688
48. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21:357-366
49. Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarui S. (1985) Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study. Clin Exp Immunol 60:622-630
50. Moffett A, Regan L, Braude P. (2004) Natural killer cells, miscarriage, and infertility. BMJ 329:1283-1285
51. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, Witte T. (2004) Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50:1561-1565
52. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A. (2002) Human natural killer cells: their origin, receptors and function. Eur J Immunol 32:1205-1211
53. Natuk RJ, Welsh RM. (1987) Accumulation and chemotaxis of natural killer/large granular lymphocytes at sites of virus replication. J Immunol 138:877-883
54. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. (2004) Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173:4273-4276
55. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, Lanier LL. (2004) NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20:757-767
56. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. (1998) Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 161:5821-5824
57. Piccioli D, Sbrana S, Melandri E, Variante NM. (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195:335-341
58. Poirot L, Benoist C, Mathis D. (2004) Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci USA 101:8102-8107
59. Poulton LD, Smyth MJ, Hawke CG, Silveira P, Shepherd D, Naidenko OV, Godfrey DI, Baxter AG. (2001) Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int Immunol 13:887-896
60. Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O, Eskelin P, Pelto-Huikko M, Peltonen L. (2002) Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 11:397-409
61. Raulet DH. (2004) Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5:996-1002
62. Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H. (2004) Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200:1123-1134
63. Rolstad B, Herberman RB, Reynolds CW. (1986) Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). J Immunol 136:2800-2808
64. Romphruk AV, Romphruk A, Choonhakarn C, Puapairoj C, Inoko H, Leelayuwat C. (2004) Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypes. Tissue Antigens 63:547-554
65. Rot A, von Andrian UH. (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891-928
66. Salazar-Mather TP, Lewis CA, Biron CA. (2002) Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1α delivery to the liver. J Clin Invest 110:321-330
67. Salazar-Mather TP, Orange JS, Biron CA. (1998) Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J Exp Med 187:1-14
68. Scribner CL, Steinberg AD. (1988) The role of splenic colony-forming units in autoimmune disease. Clin Immunol Immunopathol 49:133-142
69. Shi FD, Wang HB, Li H, Hong S, Taniguchi M, Link H, Van Kaer L, Ljunggren HG. (2000) Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1:245-251
70. Smeltz RB, Wolf NA, Swanborg RH. (1999) Inhibition of autoimmune T cell responses in the DA rat by bone marrow-derived NK cells in vitro: implications for autoimmunity. J Immunol 163:1390-1397
71. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2:850-861
72. Snyder MR, Weyand CM, Goronzy JJ. (2004) The double life of NK receptors: stimulation or co-stimulation? Trends Immunol 25:25-32
73. Stein-Streilein J, Bennett M, Mann D, Kumar V. (1983) Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection. J Immunol 131:2699-2704
74. Suzuki Y, Hamamoto Y, Ogasawara Y, Ishikawa K, Yoshikawa Y, Sasazuki T, Muto M. (2004) Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 122:1133-1136
75. Tagliabue A, Befus AD, Clark DA, Bienenstock J. (1982) Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med 155:1785-1796
76. Tak PP, Kummer JA, Hack CE, Daha MR, Smeets TJ, Erkelens GW, Meinders AE, Kluin PM, Breedveld FC. (1994) Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 37:1735-1743
77. Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T. (2004) The regulatory role of natural killer cells in multiple sclerosis. Brain 127:1917-1927
78. Takahashi K, Miyake S, Kondo T, Terao K, Hatakenaka M, Hashimoto S, Yamamura T. (2001) Natural killer type 2 bias in remission of multiple sclerosis. J Clin Invest 107:R23-R29
79. Takeda K, Dennert G. (1993) The development of autoimmunity in C57BL/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med 177:155-164
80. Todd DJ, Forsberg EM, Greiner DL, Mordes JP, Rossini AA, Borteil R. (2004) Deficiencies in gut NK cell number and function precede diabetes onset in BB rats. J Immunol 172:5356-5362
81. Toyabe SI, Kaneko U, Uchiyama M. (2004) Decreased DAP 12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations. J Autoimmun 23:371-378
82. Traugott U. (1985) Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions. Springer Semin Immunopathol 8:71-95
83. Trembleau S, Germann T, Gately MK, Adorini L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 16:383-386
84. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52:2639-2642
85. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317
86. Wiltrout RH, Mathieson BJ, Talmadge JE, Reynolds CW, Zhang SR, Herberman RB, Ortaldo JR. (1984) Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 160:1431-1449
87. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. (1997) A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 100:1059-1070
88. Yabuhara A, Yang FC, Nakazawa T, Iwasaki Y, Mori T, Koike K, Kawai H, Komiyama A. (1996) A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus. J Rheumatol 23:171-177
89. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ. (2001) Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193:1159-1167
90. Yokoyama WM, Kim S, French AR. (2004) The dynamic life of natural killer cells. Annu Rev Immunol 22:405-429
91. Yoneda O, Imai T, Goda S, Inoue H, Yamauchi A, Okazaki T, Imai H, Yoshie O, Bloom ET, Domae N, Umehara H. (2000) Fractalkine-mediated endothelial cell injury by NK cells. J Immunol 164:4055-4062
92. Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186:1677-1687